<DOC>
	<DOCNO>NCT02649725</DOCNO>
	<brief_summary>The purpose study determine whether positive ( beneficial ) impact expensive cytotoxic agent cancer patient . It questionnaire base study fill cancer patient without obligation .</brief_summary>
	<brief_title>Patients Satisfaction With Outcomes Expensive Cytotoxic Agents</brief_title>
	<detailed_description>This prospective observational questionnaire base study measure degree patient satisfaction outcomes expensive cytotoxic agent . The tested drug trastuzumab , lapatinib , sunitinib , tor inhibitor , sorafenib , cetuximab , panitumumab , bevacizumab , erlotinib , rituximab , imatinib mesylate , gefitinib , abiraterone acetate , cabazitaxel , pertuzumab , fulvestrant , pemetrexate crizotinib . The evaluation predesigned template questionnaire apply test drug . The question divide five category measure five item , negative impact drug patient 's finance , satisfaction drug efficacy , toxicity effect quality life , satisfaction drug availability market satisfaction receive education treat physician drug usage . A predesigned questionnaire base score system categorizes process data low , intermediate high score five measure topic . The data process drug acquire low , moderate high score . Subsequent recommendation revision drug price , cost effective analysis study , physician education drug pharmaceutical perspective elaborate drug . The study clarify annoy frequently report side effect drug suggest recommendation treatment . The study currently recruit patient . The study currently accept add author ( Oncology physician ) fulfill follow prerequisite : 1 . Answer questionnaire mail upon request propagate questionnaire 10 oncology physician center answer . ( The 11 questionnaire scan mailed ellithym @ med.asu.edu.eg . give hard copy Dr Mahmoud Ellithy ( Mobile : +01000069694 ) . ( This questionnaire design answered oncology physician measure degree satisfaction outcomes expensive cytotoxic agent ) . The questionnaire answer electronically online http : //www.surveymonkey.com/r/Cureandmore . ( oncologist foreign nationality want share author . Egyptian oncologist fill hard copy online ) . Disclosure : The Questionnaire physicians clinical trial register clinical trials.gov NCT02630979 . URL . http : //clinicaltrials.gov/ct2/show/nct02630979 . 2 . Each author must share least 90 patient least 5 patient drug . The maximum allowed number author center two author share 180 patient till closure study 30th January 2019 . 3 . Share new idea add benefit study . ( Item 1 2 mandatory ) . The Oncologist want share author study must sign memorandum aggrement consent accuracy , confidentiality validity data copyright , state must obtain write permission research team ( Cure More research team ) produce text , figure , table illustration study future work .</detailed_description>
	<criteria>Inclusion criterion : 1 . The patient willing share study . 2 . The patient full mental power answer questionnaire . 3 . Adult 17 70 year . 4 . Patient able complete course treatment without interruption due financial issue issue like transportation obstacle . Exclusion criterion : 1 . The patient psychological disease impairs credibility answer . 2 . Patient special requirements/difficulties communication . 3 . Patient difficulty memory e.g . recall event , learn new thing , remember appointment . 4 . Patient epilepsy blackout dizzy spill . 5 . Patient visual impairment standard glass .</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>